Intra-Cellular Therapies
ITCI
$67.24
Share price
2.42%
Change (1 day)
12.95%
Change (1 year)
Categories
Intra-Cellular Therapies (ITCI) - Total assets
Total assets on the balance sheet as of March 2024 : $0.74 B
According to Intra-Cellular Therapies's latest financial reports the company's total assets are $0.74 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Intra-Cellular Therapies - Total assets on balance sheet (from 2013 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.72 B | -3.51% |
| 2022-12-31 | $0.75 B | 54.06% |
| 2021-12-31 | $0.48 B | -31.7% |
| 2020-12-31 | $0.71 B | 185.57% |
| 2019-12-31 | $0.25 B | -29.68% |
| 2018-12-31 | $0.35 B | -24.24% |
| 2017-12-31 | $0.47 B | 21.23% |
| 2016-12-31 | $0.38 B | -19.67% |
| 2015-12-31 | $0.48 B | 269.23% |
| 2014-12-31 | $0.13 B | 241% |
| 2013-12-31 | $38.44 M | 93.96% |
| 2013-03-31 | $0 M | |
| 2012-12-31 | $19.82 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | $0.88 B | 18.37% | 🇺🇸 USA |
 MediciNova MNOV | $62.89 M | -91.58% | 🇺🇸 USA |
 Curis CRIS | $62.02 M | -91.70% | 🇺🇸 USA |